Vann Healthcare Recalls Hydroxyprogesterone Caproate Due to Sterility Concerns
Vann Healthcare Services is recalling Hydroxyprogesterone Caproate vials because an FDA inspection found deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Vann Healthcare Services Inc is recalling Hydroxyprogesterone Caproate, 250 mg per mL, 5 mL vials. The product is a prescription medication distributed in Kentucky.
The recall was initiated following a recent FDA inspection of the Vann Healthcare Services facility. The inspection revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure the sterility of their products.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Hydroxyprogesterone Caproate, 250 mg per mL, 5 mL vial, Rx, Vann Healthcare Pharmacy, 1220 N Race Street, Glasgow, KY 42141
- Manufacturer
- Vann Healthcare Services Inc
- Category
- Drug — Prescription Injectable
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot #: 071714A
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 4 recalled by Vann Healthcare Services Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Vann Healthcare Services Inc
See all →- SevereVann Healthcare Recalls Epinephrine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
- SevereVann Healthcare Recalls Lidocaine Syringes Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
- SevereVann Healthcare Pharmacy Recalls Tri-mix #4 Due to Sterility Concerns
FDA (Drugs) · 2014-12-31
Same hazard · sterility concern
See all →- HighSegmental Stem Components for ELEOS Limb Salvage System Recalled
FDA (Devices) · 2025-06-04
- HighMEDIHONEY Dressing Applicator Pouch Recalled for Sterility Concerns
FDA (Devices) · 2024-10-16
- HighProparacaine Hydrochloride Eye Drops Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-10-02
- HighExactech OPTETRAK Knee Implants Recalled for Out-of-Specification Vacuum Bag Packaging
FDA (Devices) · 2024-06-26
- HighPantoprazole Sodium for Injection Recalled Due to Sterility Concern
FDA (Drugs) · 2023-09-20
Similar recalls
- SevereGreen Valley Drugs Recalls Hydroxyprogesterone Caproate Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- ModerateApothecary Shoppe Recalls Hydroxyprogesterone Caproate Vials for Sterility Concerns
FDA (Drugs) · 2015-08-12
- SevereFDA Recalls Hydroxyprogesterone Caproate Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-09-23
- SevereRecall of Hydroxyprogesterone Caproate Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-03-12
- SevereColonia Care Pharmacy Recalls C-Hydroxyprogesterone Caproate Injections for Sterility Concerns
FDA (Drugs) · 2019-10-09
- Severe